Interest Income Expense - Nektar Therapeutics (NASDAQ:NKTR) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 1.83 USD 3.39%

Updated:

Nektar Therapeutics
Interest Income Expense

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Nektar Therapeutics
Interest Income Expense Peer Comparison

JNJ

BMY

PFE

MRK

LLY

Company		Interest Income Expense	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Nektar Therapeutics NASDAQ:NKTR	Interest Income Expense -$5.3m	CAGR 3-Years 42%	CAGR 5-Years N/A	CAGR 10-Years 18%
	Johnson & Johnson NYSE:JNJ	Interest Income Expense $212m	CAGR 3-Years -29%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Bristol-Myers Squibb Co NYSE:BMY	Interest Income Expense -$676m	CAGR 3-Years N/A	CAGR 5-Years -26%	CAGR 10-Years N/A
	Pfizer Inc NYSE:PFE	Interest Income Expense $1.5B	CAGR 3-Years 130%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Merck & Co Inc NYSE:MRK	Interest Income Expense -$1.2B	CAGR 3-Years N/A	CAGR 5-Years -30%	CAGR 10-Years -13%
	Eli Lilly and Co NYSE:LLY	Interest Income Expense -$368m	CAGR 3-Years -133%	CAGR 5-Years -10%	CAGR 10-Years -30%

See Also

Based on the financial report for Mar 31, 2024, Nektar Therapeutics's Interest Income Expense amounts to -5.3m USD.

Over the last year, the Interest Income Expense growth was 70%. The average annual Interest Income Expense growth rates for Nektar Therapeutics have been 42% over the past three years , and 18% over the past ten years .

Join more than 137,800+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.